Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

FDA Approves Two Additional Indications for Rivaroxaban in Children

L.A. McKeown

December 21, 2021

News Features

World-wise: As In-Person Meetings Resume, Global Voices Hope to Be Heard

Shelley Wood

December 13, 2021

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Shelley Wood

November 08, 2021

Presentation TCT 2021

Special Considerations of Valve Hemodynamics and Prosthesis-Patient Mismatch Following Valve-in-Valve

Presenter: Janarthanan Sathananthan

November 06, 2021

Presentation TCT 2021

TAV in TAV: The First TAVR Matters

Presenter: Janarthanan Sathananthan

November 04, 2021

News Daily News

Tailored TAVI: Standardizing Balloon Pressures May Curb Operator Angst

L.A. McKeown

October 28, 2021

News Daily News

Rivaroxaban Again Linked to More Bleeding vs Other DOACs

Caitlin E. Cox

October 11, 2021

News CV Team Pro

Keith Tottenham

L.A. McKeown

June 23, 2021

News Conference News ACC 2021

ATLANTIS: Apixaban Has No Benefit Over Standard of Care Post-TAVI

Yael L. Maxwell

May 15, 2021

News Daily News

DOACs Safe, Effective in Subset of Valvular AF Patients

Shelley Wood

March 31, 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2021

Shelley Wood

February 03, 2021

News Daily News

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

Michael O'Riordan

January 28, 2021

News Daily News

Cerebral Embolic Protection Use Low During TAVI, Not Tied to Stroke Risk

Todd Neale

January 20, 2021

News Daily News

Unplanned PCI Rare After TAVI, but Operators Get Good Results

Michael O'Riordan

January 18, 2021

News Daily News

LAA Occlusion With Amplatzer Amulet May Have Edge Over DOACs

Todd Neale

January 08, 2021

News Opinion CV Team Dispatch

January 2021 News Roundup

L.A. McKeown

January 01, 2021

Advertisement

FDA Approves Two Additional Indications for Rivaroxaban in Children

World-wise: As In-Person Meetings Resume, Global Voices Hope to Be Heard

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Special Considerations of Valve Hemodynamics and Prosthesis-Patient Mismatch Following Valve-in-Valve

TAV in TAV: The First TAVR Matters

Tailored TAVI: Standardizing Balloon Pressures May Curb Operator Angst

Rivaroxaban Again Linked to More Bleeding vs Other DOACs

Keith Tottenham

ATLANTIS: Apixaban Has No Benefit Over Standard of Care Post-TAVI

DOACs Safe, Effective in Subset of Valvular AF Patients

TCTMD’s Top 10 Most Popular Stories for January 2021

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

Cerebral Embolic Protection Use Low During TAVI, Not Tied to Stroke Risk

Unplanned PCI Rare After TAVI, but Operators Get Good Results

LAA Occlusion With Amplatzer Amulet May Have Edge Over DOACs

January 2021 News Roundup

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content